e-learning
resources
Stockholm 2002
Monday 16.09.2002
Pulmonary surfactant in the pathogenesis and treatment of acute respiratory failure
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evidence of muscle wasting in SP-C/TNFα mice
R. C. J. Langen, A. M. W. J. Schols, M. C. J. M. Kelders, J. L. J. van der Velden, E. F. M. Wouters, Y. M. W. Janssen-Heininger (Maastricht, The Netherlands; Burlington, United States Of America)
Source:
Annual Congress 2002 - Pulmonary surfactant in the pathogenesis and treatment of acute respiratory failure
Session:
Pulmonary surfactant in the pathogenesis and treatment of acute respiratory failure
Session type:
Oral Presentation
Number:
2334
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. C. J. Langen, A. M. W. J. Schols, M. C. J. M. Kelders, J. L. J. van der Velden, E. F. M. Wouters, Y. M. W. Janssen-Heininger (Maastricht, The Netherlands; Burlington, United States Of America). Evidence of muscle wasting in SP-C/TNFα mice. Eur Respir J 2002; 20: Suppl. 38, 2334
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Lane-hamilton syndrome and CCF: a fatal association
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Evidence for early onset of skeletal muscle abnormalities in smoking mice
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008
Skeletal muscle inflammatory markers in COPD patients with muscle wasting
Source: Annual Congress 2010 - Novel markers of lung injury
Year: 2010
Decreased expression of genes involved in skeletal muscle oxidative metabolism in COPD patients with muscle wasting
Source: Annual Congress 2008 - Respiratory muscle pathophysiology
Year: 2008
Evidence of sarcomere disruption and myofibrilar degeneration in the quadriceps muscle of stable COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 552s
Year: 2003
GSK-3β is required for the induction of skeletal muscle atrophy
Source: Annual Congress 2010 - Distortions of the respiratory system in the lung function
Year: 2010
Hypoxia signaling and muscle mass regulation in skeletal muscle of mice exposed to hypoxia
Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles
Year: 2010
Effects of inflammation on skeletal muscle
Source: ISSN=1025-448x, ISBN=1-904097-27-8, page=68
Year: 2003
Comparison of different methods to screen skeletal muscle function in chronic wasting diseases
Source: Eur Respir J 2001; 18: Suppl. 33, 22s
Year: 2001
Hypogonadism is related to skeletal muscle weakness in male patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 256s
Year: 2004
Hypoxia sensitizes skeletal muscle to fasting-induced muscle atrophy; role of AMPK activation
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015
Pectoralis muscle area and skeletal muscle strength in patients with ILD
Source: International Congress 2016 – From cardiopulmonary interaction to locomotor muscles and dyspnoea in health and disease
Year: 2016
In vitro and in vivo contractile properties of the vastus lateralis muscle in males with COPD
Source: Eur Respir J 2003; 21: 273-278
Year: 2003
Decreased muscle PPAR concentrations: a mechanism underlying skeletal muscle abnormalities in COPD?
Source: Eur Respir J 2007; 30: 191-193
Year: 2007
Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters
Source: Eur Respir J 2004; 23: 703-707
Year: 2004
Features of skeletal muscle dysfunction in COPD patients with obesity
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Hypoxia-induced muscle atrophy and impaired regulation of protein turnover are partially dependent on muscle glucocorticoid receptor signaling
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
IL-6 causes respiratory and peripheral muscle atrophy in rats
Source: Eur Respir J 2003; 22: Suppl. 45, 573s
Year: 2003
The clinical impact of skeletal muscle dysfunction
Source: Annual Congress 2008 - PG3 - Respiratory physiology: respiratory and peripheral muscle function in health and disease
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept